The FDA has approved vonoprazan (Voquezna), a new daily treatment for heartburn associated with GERD in adults. andreswd/Getty Images Adults with a certain type of heartburn now have another option ...

This retrospective study shows that among nearly 160,000 patients with pulmonary hypertension (PH), those who also had gastroesophageal reflux disease (GERD) had lower rates of morbidity and mortality ...

Add Yahoo as a preferred source to see more of our stories on Google. If your doctor has diagnosed you with acid reflux or gastroesophageal reflux disease (GERD), you’re all too familiar with the ...

Compared with conventional Western medicine, nonpharmacologic therapies, either alone or combined with other treatments, more effectively increased lower esophageal sphincter pressure and reduced ...

Acid reflux is when stomach acid flows into the esophagus and mouth, causing heartburn. GERD is a chronic form of acid reflux, and it can lead to serious health problems if untreated. Triggers of GERD ...

Idiopathic pulmonary fibrosis (IPF) is a rapidly progressive, fatal disease of unknown cause. Although there is no known cure, there have been indications that gastroesophageal reflux disease (GERD) ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...

You've just finished your favorite spicy meal when you notice your voice suddenly sounds hoarse. You don't have a fever or ...